Amgen, Adaptive to develop Covid-19 drugs using antibodies from recovered patients
The companies are tapping a longstanding partnership and said they would finalize financial details and terms in the coming weeks. The effort will involve using neutralizing antibodies against SARS-CoV-2 from hundreds of Covid-19 patients.